Henze, M., Mohammed, A. B., Mier, W., Rudat, V., Dietz, A., Nollert, J., . . . Haberkorn, U. (2002). Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18 F-fluorodeoxyglucose, 123 I-α-methyl-L-tyrosine and 99m Tc-hexakis-2-methoxyisobutylisonitrile. European journal of nuclear medicine and molecular imaging, 29(3), . https://doi.org/10.1007/s00259-001-0703-3
Chicago-Zitierstil (17. Ausg.)Henze, Marcus, Ashour B. Mohammed, Walter Mier, Volker Rudat, Andreas Dietz, Jörg Nollert, Michael Eisenhut, und Uwe Haberkorn. "Pretreatment Evaluation of Carcinomas of the Hypopharynx and Larynx with 18 F-fluorodeoxyglucose, 123 I-α-methyl-L-tyrosine and 99m Tc-hexakis-2-methoxyisobutylisonitrile." European Journal of Nuclear Medicine and Molecular Imaging 29, no. 3 (2002). https://doi.org/10.1007/s00259-001-0703-3.
MLA-Zitierstil (9. Ausg.)Henze, Marcus, et al. "Pretreatment Evaluation of Carcinomas of the Hypopharynx and Larynx with 18 F-fluorodeoxyglucose, 123 I-α-methyl-L-tyrosine and 99m Tc-hexakis-2-methoxyisobutylisonitrile." European Journal of Nuclear Medicine and Molecular Imaging, vol. 29, no. 3, 2002, https://doi.org/10.1007/s00259-001-0703-3.